Mesoblast (MEOBF) EBT Margin (2014 - 2023)
Mesoblast's (MEOBF) quarterly EBT Margin came in at 1183.77% in Q2 2023, down 922281.0% year-over-year from N/an in Q2 2022, and down 23.1% quarter-over-quarter from 961.63% in Q1 2023.
Powered by 
Analysis
Mesoblast (MEOBF) EBT Margin (2014 - 2023) Analysis & Trends
Mesoblast has disclosed EBT Margin across 10 years of filings, most recently posting 1183.77% for Q2 2023.
- In Q2 2023, EBT Margin fell 922281.0% year-over-year to 1183.77%; the TTM figure through Jun 2023 stood at 1104.84% (down 192610.0% YoY), while the FY2026 annual figure was 47.31%, down 54469.0% from the prior year.
- EBT Margin came in at 1183.77% for Q2 2023 at Mesoblast, down from 961.63% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 9042.11% in Q2 2021 to a low of 2175.74% in Q1 2019.
- Average EBT Margin over 5 years is 71.28%, with a median of 1061.51% recorded in 2022.
- Year-over-year, EBT Margin jumped 201205 bps in 2020 and slumped 922281 bps in 2023.
- Over 5 years, EBT Margin stood at 949.28% in 2019, then declined by 20 bps to 1143.15% in 2020, then jumped by 36 bps to 736.0% in 2021, then slumped by 56 bps to 1150.75% in 2022, then fell by 3 bps to 1183.77% in 2023.
- Per Business Quant data, the three most recent EBT Margin figures were 1183.77% in Q2 2023, 961.63% in Q1 2023, and 1150.75% in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.42 Bn | 112.79 Mn | 55.43% |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | -885.91% |
| 3 | Iovance Biotherapeutics | 3.78 Bn | 3.49 Bn | 55.72 Mn | -49.02% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 14.32% |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn | -1,356.24% |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | -24,299.18% |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 36.51% |
| 8 | Sarepta Therapeutics | 2.35 Bn | 1.55 Bn | 251.87 Mn | -0.44% |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 2.88% |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -1,183.77% |
| Mar 31, 2023 | -961.63% |
| Dec 31, 2022 | -1,150.75% |
| Sep 30, 2022 | -1,127.01% |
| Jun 30, 2022 | 8,039.04% |
| Mar 31, 2022 | -1,061.51% |
| Dec 31, 2021 | -736.00% |
| Sep 30, 2021 | -631.80% |
| Jun 30, 2021 | 9,042.11% |
| Mar 31, 2021 | -1,389.71% |
| Dec 31, 2020 | -1,143.15% |
| Sep 30, 2020 | -1,936.70% |
| Mar 31, 2020 | -163.69% |
| Dec 31, 2019 | -949.28% |
| Sep 30, 2019 | -43.50% |
| Jun 30, 2019 | -1,215.20% |
| Mar 31, 2019 | -2,175.74% |
| Dec 31, 2018 | -1,468.93% |
| Sep 30, 2018 | -173.66% |
| Jun 30, 2018 | -1,285.59% |